Pages that link to "Q34486075"
Jump to navigation
Jump to search
The following pages link to Standardized remission criteria in schizophrenia. (Q34486075):
Displaying 50 items.
- Definition and description of schizophrenia in the DSM-5 (Q22251472) (← links)
- Risperidone versus other atypical antipsychotics for schizophrenia (Q24234950) (← links)
- Olanzapine versus other atypical antipsychotics for schizophrenia (Q24236545) (← links)
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia (Q24607361) (← links)
- A systematic review and meta-analysis of recovery in schizophrenia (Q26859162) (← links)
- Symptomatic remission in a multiracial urban population of older adults with schizophrenia (Q30437691) (← links)
- Executive function does not predict coping with symptoms in stable patients with a diagnosis of schizophrenia (Q33338658) (← links)
- Seventeen-year clinical outcome of schizophrenia in Bali (Q33940291) (← links)
- Current status specifiers for patients at clinical high risk for psychosis (Q34123531) (← links)
- Clinical relevance of findings in trials of antipsychotics: systematic review (Q34180797) (← links)
- Biologically flavored perspectives on Garmezian resilience (Q34257794) (← links)
- Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders (Q35057412) (← links)
- Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders. (Q35096476) (← links)
- Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia (Q35136003) (← links)
- Social Cognition as a Mediator Variable Between Neurocognition and Functional Outcome in Schizophrenia: Empirical Review and New Results by Structural Equation Modeling (Q35176730) (← links)
- Remission and recovery during the first outpatient year of the early course of schizophrenia (Q35211161) (← links)
- Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later (Q35237264) (← links)
- No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder (Q35715158) (← links)
- Quantifying Clinical Relevance in the Treatment of Schizophrenia (Q35819467) (← links)
- Early-Life Stress Affects Stress-Related Prefrontal Dopamine Activity in Healthy Adults, but Not in Individuals with Psychotic Disorder (Q35967475) (← links)
- Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome (Q36072624) (← links)
- Determinants of subjective and objective burden of informal caregiving of patients with psychotic disorders (Q36146756) (← links)
- Symptomatic Remission in Schizophrenia and its Relationship with Functional Outcome Measures in Indian Population (Q36301117) (← links)
- Definitions of recovery and outcomes of major depression: results from a 10-year follow-up. (Q36477463) (← links)
- Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics (Q36853291) (← links)
- Remission in schizophrenia: the relationship to baseline symptoms and changes in symptom domains during a one-year study (Q37031581) (← links)
- Clinical recovery in first-episode psychosis (Q37137014) (← links)
- The impact of supported employment and working on clinical and social functioning: results of an international study of individual placement and support (Q37310171) (← links)
- The Use of the Health of the Nation Outcome Scales for Assessing Functional Change in Treatment Outcome Monitoring of Patients with Chronic Schizophrenia (Q37336548) (← links)
- Outcomes of FLEXIBLE Assertive Community Treatment (FACT) Implementation: A Prospective Real Life Study (Q37413523) (← links)
- Managing schizophrenia in primary care: the utility of remission criteria as outcome indicators (Q37421545) (← links)
- Measuring psychosocial outcomes in schizophrenia patients (Q37834221) (← links)
- Refractoriness in Bipolar Disorder: Definitions and Evidence‐Based Treatment (Q37954423) (← links)
- Clinical characteristics of patients who have recovered from schizophrenia: the role of empathy and positive‐self schema (Q38024139) (← links)
- Early intervention in schizophrenia in developing countries: focus on duration of untreated psychosis and remission as a treatment goal (Q38051437) (← links)
- The onset and offset of psychosis--and what happens in between--a commentary on ‘Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 Study’ by Morgan et al. (2014). (Q38234436) (← links)
- The cumulative needs for care monitor: a unique monitoring system in the south of the Netherlands (Q39493347) (← links)
- Psychometric properties of a performance-based measurement of functional capacity, the UCSD Performance-based Skills Assessment - Brief version (Q39646534) (← links)
- Genetic variability testing of neurodevelopmental genes in schizophrenic patients (Q41662134) (← links)
- Therapeutic relationships: their specificity in predicting outcomes for people with psychosis using clinical and vocational services (Q42639743) (← links)
- Supporting positive dimensions of health, challenges in mental health care (Q42743424) (← links)
- Symptomatic resolution among Chinese patients with schizophrenia and associated factors. (Q43055455) (← links)
- Cognitive alterations in patients with non-affective psychotic disorder and their unaffected siblings and parents (Q44741809) (← links)
- A symptom self-rating scale for schizophrenia (4S): psychometric properties, reliability and validity (Q46078763) (← links)
- Five-year follow-up during antipsychotic treatment: efficacy, safety, functional and social outcome (Q46937654) (← links)
- Therapeutic relationships in vocational rehabilitation: Predicting good relationships for people with psychosis (Q48170552) (← links)
- Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia (Q48255357) (← links)
- Effectiveness and tolerability of long-acting risperidone: A 9-month open-label extension of a 12-week switching study from oral antipsychotics (Q48414001) (← links)
- Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission? (Q48838612) (← links)
- Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances (Q49590987) (← links)